Streamline MedTech (Beijing) Co., Ltd
HomePage-BookMark-简体中文
  • Home
  • Who We Are
  • Services
  • Why Streamline
  • Resources
  • Contact Us

Resources

Regulatory Systems
Useful Links
News and Events

News and Events

China: US FDA: $10M in CR to Add More Capacity in China for Inspections

“Proposed US government funding plans include $10m the FDA will use to increase oversight of drug manufacturing and research in China.”

http://www.biopharma-reporter.com/Bio-Developments/US-FDA-10M-in-CR-to-Add-More-Capacity-in-China-for-Inspections

 

 

 

 

 

 

Previous:China: Will the Asian Clinical Trial Boom Turn to Bust
版权所有 © 2014-2024 思澜医药
京ICP备14009238号-1

Streamline MedTech (Beijing) Co., Ltd

Telephone: +86 10 6253 0237

本站基于 米拓企业建站系统 7.3.0 搭建